According to bc-GenExMiner v4.3, estrogen receptor or progesterone receptor-positive (IHC) breast cancer patients were with higher PTPRT levels, while HER2+ (IHC) breast cancer patients were with lower PTPRT level. Here, ESR1 is linked to breast carcinoma.